Multicenter Epidemiological Study for the Evaluation of the Seroprevalence of Total and Neutralizing Antibodies Against Adenoassociated Virus Serotypes Used in Gene Therapy in Patients With Neuromuscular Diseases of Genetic Origin.

NCT07633951 · clinicaltrials.gov ↗

NA

Phase

NOT_YET_RECRUITING

Status

450

Enrollment

OTHER

Sponsor class

Conditions

Neuromuscular Deficits
Genetic Disorder

Interventions

DIAGNOSTIC_TEST: Dosage of AAV neutralizing antibodies

Sponsor

Genethon